[1]
“Multigene expression signatures in early hormone receptor positive HER 2 negative breast cancer”, Radiol Oncol, vol. 53, no. 3, pp. 285–292, Sep. 2019, Accessed: Sep. 15, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/3240